Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin

Journal of Dermatological Science

Volumn 14, Issue 3, 1997, Pages 179-188

  Gerritsen, M J P ^a   Elbers, M E ^a   De Jong, E M G J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Filaggrin; Involucrin; Ki 67; Margin zone psoriatic skin; Tenascin; Uninvolved skin

Indexed keywords

FILAGGRIN; INVOLUCRIN; KI 67 ANTIGEN; TENASCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KERATINIZATION; MALE; PRIORITY JOURNAL; PSORIASIS;

ADULT; AGED; BIOPSY; CELL DIVISION; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PSORIASIS; SKIN; TENASCIN;

EID: 0031106857     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00570-1     Document Type: Article

References (43)

1. [1] Burks JW: Histopatbologic study of psoriasis. Arch Dermatol Syph 48: 479-494, 1943.
2. [2] Braun-Falco O: Zur Morphogenese der psoriatischen Hautreaktion. Eine morphologischen-bistochemische Studie. Arch Klin Exp Derm 217: 130-154, 1963.
3. [3] Pinkus H, Mehregan AH: The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 46: 109-117, 1966.
4. [4] Christophers E, Braun-Falco O: Psoriatic hyperplasia: some measurements. Br J Dermatol 83, Jubilee Issue: 63-69, 1970.
5. [5] Soltani K, Scott van E: Patterns and sequence of tissue changes in incipient and evolving lesions of psoriasis. Arch Dermatol 106: 484-491, 1972.
6. [6] Cox A, Watson W: Histological variations in lesions of psoriasis. Arch Dermatol 106: 503-507, 1972.
7. [7] Christophers E, Parzefall R, Braun-Falco O: Initial events in psoriasis: quantitative assessment. Br J Dermatol 89: 327-334, 1973.
8. [8] Braun-Falco O, Christophers E: Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch 251: 95-110, 1974.
9. [9] Chowaniec O, Jablonska S: Pre-pin-point papules changes preceding pin-point lesions of psoriasis. Acta Derm-Venereol 59 (suppl 85): 39-45, 1979.
10. [10] Braun-Falco O: The initial psoriatic lesion. In: Proceedings of the Second International Symposium. Yorke Medical Books, 1977, pp. 1-11.
11. [11] Ragaz A, Ackerman AB: Evolution, maturation, and regression of lesions of psoriasis. Am J Dermalopathol 1: 199-215, 1979.
12. [12] Chowaniec O, Jablonska O, Beutner EH et al.: Earliest clinical and histological changes in psoriasis. Dermatologica 163: 42-51, 1981.
13. [13] Mier PD, Cotton DWK: Psoriasis. In: The Molecular Biology of Skin. Blackwell, Oxford, 1976, pp. 375-404.
14. [14] Schalkwijk J, Vlijmen-Willems IMJJ van, Oosterling B: Tenascin expression in hyperproliferative skin diseases. Br J Dermatol 124: 13-20, 1991.
15. [15] Kerkhof van de PCM, Rennes H van, Grood R de: Metabolic changes at the margin of the spreading psoriatic lesion. Br J Dermatol 108: 647-652, 1983.
16. [16] Hull MS, Goodfield M, Wood EJ, Cunliffe WJ: Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser-Doppler flowmetry and immunocytochemical techniques. J Invest Dermatol 92: 782-785, 1989.
17. [17] Mare de S, Jong de EMGJ, Erp van PEJ, Kerkhof PCM van de: Markers for proliferation and keratinization in the margin of the active psoriatic lesion. Br J Dermatol 122: 469-475, 1990.
18. [18] Jong de EMGJ, Schalkwijk J, Kerkhof van de PCM: Epidermal proliferation and differentiation, composition of the inflammatory infiltrate and the extracellular matrix in the margin of the spreading psoriatic lesion. Eur J Dermatol 1: 221-227, 1991.
19. [19] Sibrack LA, Gray RH, Bernstein IA Localization of histidine-rich protein in keratohyalin: a morphologic and macromolecular marker in epidermal differentiation: J Invest Dermatol 62: 394-405, 1974.
20. [20] Dale BA, Lonsdale-Eccles JD, Holbrook KA: Stratum corneum basic protein: an interfilamentaous matrix protein of epidermal keratin. In: Biochemistry of Normal and Abnormal Epidermal Differentiation. Edited by IA Bernstein, M Seiji. University of Tokyo Press, Tokyo, 1980, pp. 311-325.
21. [21] Voorhees JJ, Chakrabarti SG, Bernstein IA: The metabolism of 'histidine-rich' protein in normal and psoriatic keratinization. J Invest Dermatol 51: 344-354, 1968.
22. [22] Rice RH, Green H: Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 18: 681-694, 1979.
23. [23] Watt FM: Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81: 100-103, 1983.
24. [24] Banks-Schlegel S, Green H: Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J Cell Biol 90: 732-737, 1981.
25. [25] Gerdes J, Lemke H, Baisch H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984.
26. [26] Rijzewijk JJ, Erp van PEJ, Bauer FW: Two binding sites for Ki-67 related to quiescent and cycling cells in human epidermis. Acta Derm-Venereol 69: 512-515, 1989.
27. [27] Erp van PEJ, Mare S de, Rijzewijk JJ: A sequential double immunoenzymic staining procedure to obtain cell kinetic information in normal and hyperproliferative epidermis. J Invest Dermatol 21: 343-347, 1989.
28. [28] Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13-20, 1983.
29. [29] Mackie EJ, Chiquet-Ehrismann R, Pearson CA et al,: Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA 84: 4621-4625, 1987.
30. [30] Schalkwijk J, Steijlen PM, Vlijmen-Willems IMJJ: Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 139: 1143-1150, 1991.
31. [31] Vinesswaren N, Haneke E, Peters KP: Cross-reaction of a monoclonal anti-filaggrin antibody with glycogen. Histochemistry 87: 597-600, 1987.
32. [32] Duijnhoven HLP van, Schalkwijk J, Kranenborg MHGC: MON-150, a versatile monoclonal antibody against involucrin: characterization and applications. Arch Dermatol Res 284: 167-172, 1992.
33. [33] Mackie EJ, Halfter W, Liverani D: Induction of tenascin in healing wounds. J Cell Biol 107: 2757-2767, 1988.
34. 3: a cell biological study. Br J Dermatol 128: 666-673, 1993.
35. [35] Rulo HFC, Vlijmen-Willems IMJJ, Schalkwijk J: Normal human skin demonstrates marked site-variation of tenascin expression, not correlated to epidermal proliferation (Ki-67 binding). J Dermatol Sci 5: 54-57, 1993.
36. [36] Pearson CA, Pearson D, Shibahara S: Tenascin: cDNA cloning and induction of TGF&z.betav;. EMBO J 7: 2977-2981, 1988.
37. 4. J Invest Dermatol 84: 421-423, 1985.
38. 4 in healthy and psoriatic skin. Br J Dermatol 116: 521-524, 1987.
39. [39] De Jong EMGJ, Van Erp PEJ, Ruiter DJ, van de Kerkhof PCM: Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematodes. J Am Acad Dermatol 25: 1032-1038, 1991.
40. [40] Steylen PM, Ramaeckers FCS, Muyen van GNP, Lane EB, Leigh IM, Troyanowski SM, Link M, van de Kerkhof PCM: Distribution of keratins in monogenic disorders of keratinization: an immunohistochemical study. Br J Dermatol, submitted for publication.
41. [41] Schubert C, Christophers E: Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 277: 352-358, 1985.
42. [42] Valyi-Nagy I, Jensen PJ, Albelda SM, Rodeck U: Cytokine-induced expression of transforming growth factorα receptor in neonatal skin explants. J Invest Dermatol 99: 350-356, 1992.
43. [43] Yuspa SH, Ben T, Henning H, Lichti U: Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 42: 2344-2349, 1982.